Prosperdtx is a digital therapeutic that improves the quality of care and delivers better outcomes across integrated health networks. It combines patient data interoperability with causal machine learning technology in the delivery of healthcare.

Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

Prosperdtx is a leader in the emerging field of digital

health proactively delivering targeted support to cancer patients that they may live better lives. We are at the intersection of medical innovation and

computational technology and provide high-value support while reducing the cost of care.

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.